Evidence map›Paper›PMID 37958656›Full record

ArticleInternational journal of molecular sciences2023

Down-Regulation of CYP3A4 by the K

Susumu Ohya, Junko Kajikuri, Hiroaki Kito, Miki Matsui

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Transcriptional Up-Regulation of FBXW7 by KInternational journal of molecular sciences · 2024
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Susumu OhyaDepartment of Pharmacology, Graduate School of Medical Sciences, Nagoya City University, Nagoya 467-8601, Japan.ORCID 0000-0002-5765-0667
Junko KajikuriDepartment of Pharmacology, Graduate School of Medical Sciences, Nagoya City University, Nagoya 467-8601, Japan.ORCID 0000-0003-0598-0733
Hiroaki KitoDepartment of Pharmacology, Graduate School of Medical Sciences, Nagoya City University, Nagoya 467-8601, Japan.
Miki MatsuiDepartment of Pharmacology, Graduate School of Medical Sciences, Nagoya City University, Nagoya 467-8601, Japan.
Nagoya City University · JP

Funding

Japan Society for the Promotion of Science JP20K07071
6 · The paper itself

Abstract

The large-conductance Ca

Indexed as

Bone NeoplasmsCytochrome P-450 CYP3ACell Line, TumorCytochrome P-450 Enzyme SystemDown-RegulationDoxorubicinDrug Resistance, NeoplasmHumansLarge-Conductance Calcium-Activated Potassium Channel alpha SubunitsMaleNF-E2-Related Factor 2Proto-Oncogene Proteins c-aktCYP3A4 protein, humanCytochrome P-450 CYP3ACytochrome P-450 Enzyme SystemDoxorubicinKCNMA1 protein, humanLarge-Conductance Calcium-Activated Potassium Channel alpha SubunitsNF-E2-Related Factor 2Proto-Oncogene Proteins c-aktAkt-Nrf2Ca2+-activated K+ channelcancer spheroidCYP3A4doxorubicin resistanceKCa1.1

Identifiers

PMID37958656
PMCPMC10648085
OpenAlexW4387971861

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.